Department of Surgery, Fujita Health University, Okazaki Medical Center, Gotanda 1, Harisaki, Okazaki, Aichi, 444-0827, Japan.
Department of Gastrointestinal Surgery, Fujita Health University Bantane Hospital, Nagoya, Aichi, Japan.
World J Surg Oncol. 2024 Aug 22;22(1):215. doi: 10.1186/s12957-024-03499-y.
The da Vinci™ Surgical System, recognized as the leading surgical robotic platform globally, now faces competition from a growing number of new robotic surgical systems. With the expiration of key patents, innovative entrants have emerged, each offering unique features to address limitations and challenges in minimally invasive surgery. The hinotori™ Surgical Robot System (hinotori), developed in Japan and approved for clinical use in November 2022, represents one such entrant. This study demonstrates initial insights into the application of the hinotori in robot-assisted surgeries for patients with rectal neoplasms.
The present study, conducted at a single institution, retrospectively reviewed 28 patients with rectal neoplasms treated with the hinotori from November 2022 to March 2024. The surgical technique involved placing five ports, including one for an assistant, and performing either total or tumor-specific mesorectal excision using the double bipolar method (DBM). The DBM uses two bipolar instruments depending on the situation, typically Maryland bipolar forceps on the right and Fenestrated bipolar forceps on the left, to allow precise dissection, hemostasis, and lymph node dissection.
The study group comprised 28 patients, half of whom were male. The median age was 62 years and the body mass index stood at 22.1 kg/m. Distribution of clinical stages included eight at stage I, five at stage II, twelve at stage III, and three at stage IV. The majority, 26 patients (92.9%), underwent anterior resection using a double stapling technique. There were no intraoperative complications or conversions to other surgical approaches. The median operative time and cockpit time were 257 and 148 min, respectively. Blood loss was 15 mL. Postoperative complications were infrequent, with only one patient experiencing transient ileus. A median of 18 lymph nodes was retrieved, and no positive surgical margins were identified.
The introduction of the hinotori for rectal neoplasms appears to be safe and feasible, particularly when performed by experienced robotic surgeons. The double bipolar method enabled precise dissection and hemostasis, contributing to minimal blood loss and effective lymph node dissection.
达芬奇手术机器人系统作为全球领先的手术机器人平台,如今面临着越来越多新型机器人手术系统的竞争。随着关键专利的到期,创新型企业纷纷涌现,每家企业都提供独特的功能来解决微创手术中的局限性和挑战。hinotori 手术机器人系统(hinotori)由日本开发,于 2022 年 11 月获准用于临床,是其中的一个新进者。本研究初步展示了 hinotori 在机器人辅助直肠肿瘤手术中的应用。
本研究在一家机构进行,回顾性分析了 2022 年 11 月至 2024 年 3 月期间使用 hinotori 治疗的 28 例直肠肿瘤患者。手术技术包括放置五个端口,其中一个端口供助手使用,并使用双极电凝(DBM)进行全直肠系膜切除术或肿瘤特异性直肠系膜切除术。DBM 根据情况使用两种双极器械,通常右侧使用马里兰双极器械,左侧使用带孔双极器械,以实现精确解剖、止血和淋巴结清扫。
研究组包括 28 例患者,其中一半为男性。中位年龄为 62 岁,体重指数为 22.1kg/m²。临床分期分布为 I 期 8 例,II 期 5 例,III 期 12 例,IV 期 3 例。大多数患者(26 例,92.9%)采用双吻合器技术行前切除术。无术中并发症或转为其他手术方式。中位手术时间和操作时间分别为 257 分钟和 148 分钟。术中出血量为 15 毫升。术后并发症少见,仅有 1 例患者出现短暂性肠梗阻。中位淋巴结检出数为 18 枚,无切缘阳性。
对于直肠肿瘤,hinotori 的应用似乎是安全可行的,尤其是由经验丰富的机器人外科医生操作时。双极电凝技术实现了精确的解剖和止血,有助于减少出血量和有效进行淋巴结清扫。